RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Haba Laboratories Stock

Haba Laboratories Net Income 2024

Haba Laboratories Net Income

-2.12 B JPY

Ticker

4925.T

ISIN

JP3765130004

In 2024, Haba Laboratories's profit amounted to -2.12 B JPY, a 199.3% increase from the -707.87 M JPY profit recorded in the previous year.

The Haba Laboratories Net Income history

YEARNET INCOME (undefined JPY)
2024-2.12
2023-0.71
2022-0.27
20210.22
20201.31
20192.09
20181.6
20171.21
20160.98
20150.04
20140.92
20130.01
20120.54
20110.02
20100.27
20090.39
20080.3
20070.61
20060.37
20050.62

Haba Laboratories Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Haba Laboratories, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Haba Laboratories from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Haba Laboratories’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Haba Laboratories. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Haba Laboratories’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Haba Laboratories’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Haba Laboratories’s growth potential.

Haba Laboratories Revenue, EBIT and net profit per share

DateHaba Laboratories RevenueHaba Laboratories EBITHaba Laboratories Net Income
202412.32 B undefined-187.77 M undefined-2.12 B undefined
202312.04 B undefined-609.64 M undefined-707.87 M undefined
202212.91 B undefined-316.73 M undefined-269.03 M undefined
202114.31 B undefined226.97 M undefined216.42 M undefined
202018.37 B undefined2 B undefined1.31 B undefined
201919.25 B undefined3.1 B undefined2.09 B undefined
201817.89 B undefined2.4 B undefined1.6 B undefined
201716.14 B undefined1.77 B undefined1.21 B undefined
201614.81 B undefined1.53 B undefined982.4 M undefined
201513.18 B undefined282.85 M undefined44.83 M undefined
201413.79 B undefined1.25 B undefined916 M undefined
201313.23 B undefined428 M undefined10 M undefined
201213.58 B undefined1.04 B undefined538 M undefined
201111.81 B undefined580 M undefined22 M undefined
201011.32 B undefined892 M undefined266 M undefined
200911.18 B undefined867 M undefined393 M undefined
200811.04 B undefined663 M undefined300 M undefined
200711.03 B undefined1.14 B undefined611 M undefined
200610.78 B undefined1.02 B undefined372 M undefined
200510.08 B undefined1.19 B undefined623 M undefined

Haba Laboratories stock margins

The Haba Laboratories margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Haba Laboratories. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Haba Laboratories.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Haba Laboratories's sales revenue. A higher gross margin percentage indicates that the Haba Laboratories retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Haba Laboratories's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Haba Laboratories's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Haba Laboratories's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Haba Laboratories. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Haba Laboratories's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Haba Laboratories Margin History

Haba Laboratories Gross marginHaba Laboratories Profit marginHaba Laboratories EBIT marginHaba Laboratories Profit margin
202468.19 %-1.52 %-17.19 %
202367.86 %-5.06 %-5.88 %
202268.13 %-2.45 %-2.08 %
202171.29 %1.59 %1.51 %
202074.38 %10.88 %7.15 %
201975.38 %16.08 %10.85 %
201874.58 %13.42 %8.93 %
201775.07 %10.97 %7.52 %
201675.5 %10.3 %6.63 %
201575.68 %2.15 %0.34 %
201475.99 %9.1 %6.64 %
201374.27 %3.23 %0.08 %
201274.73 %7.62 %3.96 %
201180.84 %4.91 %0.19 %
201079.79 %7.88 %2.35 %
200978.17 %7.75 %3.51 %
200878.05 %6 %2.72 %
200780.04 %10.35 %5.54 %
200680.85 %9.47 %3.45 %
200581.52 %11.76 %6.18 %

Haba Laboratories Aktienanalyse

What does Haba Laboratories do?

Haba Laboratories ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Haba Laboratories's Profit Margins

The profit margins of Haba Laboratories represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Haba Laboratories's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Haba Laboratories's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Haba Laboratories's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Haba Laboratories’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Haba Laboratories stock

How much profit has Haba Laboratories made this year?

Haba Laboratories has made -2.12 B JPY this year.

How has the profit developed compared to last year?

The profit has increased by 199.3% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Haba Laboratories publish its earnings?

Haba Laboratories publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Haba Laboratories?

The profits of Haba Laboratories are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Haba Laboratories?

You can learn more about the earnings of Haba Laboratories by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Haba Laboratories pay?

Over the past 12 months, Haba Laboratories paid a dividend of 40 JPY . This corresponds to a dividend yield of about 2.51 %. For the coming 12 months, Haba Laboratories is expected to pay a dividend of 40 JPY.

What is the dividend yield of Haba Laboratories?

The current dividend yield of Haba Laboratories is 2.51 %.

When does Haba Laboratories pay dividends?

Haba Laboratories pays a quarterly dividend. This is distributed in the months of April, April, April, April.

How secure is the dividend of Haba Laboratories?

Haba Laboratories paid dividends every year for the past 20 years.

What is the dividend of Haba Laboratories?

For the upcoming 12 months, dividends amounting to 40 JPY are expected. This corresponds to a dividend yield of 2.51 %.

In which sector is Haba Laboratories located?

Haba Laboratories is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Haba Laboratories kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Haba Laboratories from 6/1/2024 amounting to 40 JPY, you needed to have the stock in your portfolio before the ex-date on 3/28/2024.

When did Haba Laboratories pay the last dividend?

The last dividend was paid out on 6/1/2024.

What was the dividend of Haba Laboratories in the year 2023?

In the year 2023, Haba Laboratories distributed 40 JPY as dividends.

In which currency does Haba Laboratories pay out the dividend?

The dividends of Haba Laboratories are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Haba Laboratories

Our stock analysis for Haba Laboratories Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Haba Laboratories Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.